- Home
- DATS vs CPHI Comparison
DATS vs CPHI Comparison
Compare DATS & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DATS
- CPHI
- Stock Information
- Founded
- DATS 2014
- CPHI N/A
- Country
- DATS United States
- CPHI China
- Employees
- DATS N/A
- CPHI N/A
- Industry
- DATS Computer Software: Prepackaged Software
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- DATS Technology
- CPHI Health Care
- Exchange
- DATS Nasdaq
- CPHI Nasdaq
- Market Cap
- DATS 5.2M
- CPHI 4.2M
- IPO Year
- DATS 2021
- CPHI N/A
- Fundamental
- Price
- DATS $1.74
- CPHI $0.17
- Analyst Decision
- DATS
- CPHI
- Analyst Count
- DATS 0
- CPHI 0
- Target Price
- DATS N/A
- CPHI N/A
- AVG Volume (30 Days)
- DATS 392.8K
- CPHI 379.7K
- Earning Date
- DATS 11-14-2024
- CPHI 11-13-2024
- Dividend Yield
- DATS N/A
- CPHI N/A
- EPS Growth
- DATS N/A
- CPHI N/A
- EPS
- DATS N/A
- CPHI N/A
- Revenue
- DATS $515.00
- CPHI $5,544,620.00
- Revenue This Year
- DATS N/A
- CPHI N/A
- Revenue Next Year
- DATS N/A
- CPHI N/A
- P/E Ratio
- DATS N/A
- CPHI N/A
- Revenue Growth
- DATS N/A
- CPHI N/A
- 52 Week Low
- DATS $1.01
- CPHI $0.13
- 52 Week High
- DATS $4.13
- CPHI $0.70
- Technical
- Relative Strength Index (RSI)
- DATS 47.83
- CPHI 41.29
- Support Level
- DATS $1.61
- CPHI $0.15
- Resistance Level
- DATS $1.82
- CPHI $0.20
- Average True Range (ATR)
- DATS 0.16
- CPHI 0.03
- MACD
- DATS -0.03
- CPHI -0.00
- Stochastic Oscillator
- DATS 23.21
- CPHI 55.00
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.